| Company Name: |
Alinda Chemical Ltd.
|
| Tel: |
+7 (495) 672-17-08 |
| Email: |
sale@alinda.ru |
| Products Intro: |
CAS:817635-93-1 Package:1mg Remarks:C21H19N3O3S2
|
| Company Name: |
Nanjing Dulai Biotechnology Co., Ltd.
|
| Tel: |
025-84699383-8003;025-846993838003-8003 18013301593;18013301590 |
| Email: |
njduly@126.com |
| Products Intro: |
Product Name:PU 23 CAS:817635-93-1 Purity:>=98%(HPLC) Package:100mg
|
N-[({4-[(benzylamino)sulfonyl]phenyl}amino)carbonothioyl]benzamide manufacturers
- PU23
-
- $48.00 / 5mg
-
2026-04-12
- CAS:817635-93-1
- Min. Order:
- Purity: 99.52%
- Supply Ability: 10g
|
| | N-[({4-[(benzylamino)sulfonyl]phenyl}amino)carbonothioyl]benzamide Basic information |
| Product Name: | N-[({4-[(benzylamino)sulfonyl]phenyl}amino)carbonothioyl]benzamide | | Synonyms: | N-[({4-[(benzylamino)sulfonyl]phenyl}amino)carbonothioyl]benzamide;PU 23;MRP4,PU23,resistance,PU-23,Inhibitor,inhibit,protein,PU 23,6-Mercaptopurine,multidrug;Benzamide, N-[[[4-[[(phenylmethyl)amino]sulfonyl]phenyl]amino]thioxomethyl]-;N-((4-(N-Benzylsulfamoyl)phenyl)carbamothioyl)benzamide;PU23, 10 mM in DMSO | | CAS: | 817635-93-1 | | MF: | C21H19N3O3S2 | | MW: | 425.52 | | EINECS: | | | Product Categories: | | | Mol File: | 817635-93-1.mol | ![N-[({4-[(benzylamino)sulfonyl]phenyl}amino)carbonothioyl]benzamide Structure](CAS/20180601/GIF/817635-93-1.gif) |
| | N-[({4-[(benzylamino)sulfonyl]phenyl}amino)carbonothioyl]benzamide Chemical Properties |
| density | 1.373±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | form | Solid | | pka | 8.45±0.70(Predicted) | | color | Off-white to yellow |
| | N-[({4-[(benzylamino)sulfonyl]phenyl}amino)carbonothioyl]benzamide Usage And Synthesis |
| Uses | PU 23 is a non-carboxylic multidrug resistance protein 4 (MRP4) inhibitor as an active agent reducing resistance to anticancer agent 6-Mercaptopurine[1]. | | storage | Store at -20°C | | References | [1] Ya Chen, et al. Discovery of novel multidrug resistance protein 4 (MRP4) inhibitors as active agents reducing resistance to anticancer drug 6-Mercaptopurine (6-MP) by structure and ligand-based virtual screening. PLoS One. 2018 Oct 15;13(10):e0205175. DOI:10.1371/journal.pone.0205175 |
| | N-[({4-[(benzylamino)sulfonyl]phenyl}amino)carbonothioyl]benzamide Preparation Products And Raw materials |
|